Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers
Authors:
- Juan-Enrique SchwarzeJSJuan-Enrique Schwarze
- Christos VenetisCVChristos Venetis
- Silvia IniestaSISilvia Iniesta
- Edel FallaEFEdel Falla
- Vasily LukyanovVLVasily Lukyanov
- Elena de Agustin CalvoECElena de Agustin Calvo
- Thomas D´hOogheTDThomas D´hOoghe
- Claudia RoederCRClaudia Roeder
- Roberto MatorrasRMRoberto Matorras
Open Access
- 7 February 2022
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 85 (Pt B) , 203-216
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Development of Gonadotropins for Clinical Use in the Treatment of InfertilityFrontiers in Endocrinology, 2019
- A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in GermanyInternational Journal of Women's Health, 2019
- A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertilityInternational Journal of Women's Health, 2016
- Budget Impact Analysis Of The Introduction Of Biosimilars In A Belgian Tertiary Care Hospital: A SimulationValue in Health, 2016
- Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In PortugalValue in Health, 2016
- Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main StudyReproductive Biology and Endocrinology, 2016
- A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian ContestValue in Health, 2015
- Biossimilars, Are they Really Cost Saving? The Case of Recombinant Human Follicle Stimulating Hormone in PortugalValue in Health, 2015
- A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVFReproductive BioMedicine Online, 2015
- Biosimilar recombinant follicle stimulating hormones in infertility treatmentExpert Opinion on Biological Therapy, 2014